Skip to main content

Lupus

Is Rituximab and Belimumab the Combination to Beat Lupus? Dr. Eric Dein ( @ericdeinmd ) shares learnings from #EULAR2021. https://t.co/r4aNG7KR5h https://t.co/2kedsCL904
Dr. John Cush @RheumNow( View Tweet )
Jun 21, 2021
Watch: Lupus and the Economic Burden of Mental Health https://t.co/Ag3oz6U4mF https://t.co/cA5LmGRImf
Dr. John Cush @RheumNow( View Tweet )
Jun 20, 2021
Watch: Sex Differences in Autoimmune Disease Susceptibility: Drs. Yusof and Robinson https://t.co/rvva90SQfg https://t.co/evYgTUCS1V
Dr. John Cush @RheumNow( View Tweet )
Jun 18, 2021
How do we measure success in lupus? Dr. Kathryn Dao ( @KDAO2011 ) discusses abstract OP0296, "The 2021 DORIS Definition of Remission in SLE - Final Recommendations From an International Task Force", presented at the #EULAR2021 meeting. https://t.co/7thqrfIqnL https://t.co/iXKfcbtDfv
Dr. John Cush @RheumNow( View Tweet )
Jun 17, 2021
Ten Things to Tell Patients About Diet and Rheumatic Disease: Dr. Eric Dein ( @ejdein1 ) https://t.co/q2Mc1gLZig https://t.co/iV5JO8m5Sv
Dr. John Cush @RheumNow( View Tweet )
Jun 16, 2021

Current approach to lupus and pregnancy

Jun 14, 2021

All of us are extremely cautious with lupus patients when it comes to pregnancy. Presentation 6888 (Common issues in pregnancy management in lupus and anti-phospholipid syndrome by Dr. Rebecca Fischer-Betz) was an excellent overview of our current approach to lupus and pregnancy. 

Read Article
Exciting news for lupus treatment. Dr. Kathryn Dao ( @KDAO2011) discusses Iberdomide for lupus. #EULAR2021 https://t.co/x5tWgwBMaB https://t.co/HIaXbgRRuN
Dr. John Cush @RheumNow( View Tweet )
Jun 14, 2021
What is the impact of mental health and nephritis on SLE? Watch the video from Dr. Janet Pope ( @Janetbirdope ) as she reviews abstract POS0351, POS0681 and POS0304 presented at the virtual #EULAR2021 meeting. https://t.co/neJIdKkhJi https://t.co/YGXUHBsG3d
Dr. John Cush @RheumNow( View Tweet )
Jun 12, 2021

RheumNow Podcast - Best of EULAR 2021

Jun 11, 2021

Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting.

Read Article

How Do You Measure Success When It Comes to SLE?

Jun 10, 2021

EULAR 2021 opened with a grand debate to answer this essential question:  should clinicians treat to remission or to Lupus Low Disease Activity State (LLDAS)?  

Read Article
Promising options to treat mucocutaneous disease in SLE #EULAR2021 https://t.co/JoChBNRfqu https://t.co/6jjhuEOQgO
Dr. John Cush @RheumNow( View Tweet )
Jun 09, 2021
Video: Combination DMARD for Lupus Nephritis: Dr. Kathryn Dao ( @KDAO2011 ) #EULAR2021 https://t.co/RGVZ6jukYy https://t.co/PTjSOfM7YQ
Dr. John Cush @RheumNow( View Tweet )
Jun 09, 2021

Lessons learned in SLE

An analysis of SLE samples from SLE 1760 patients with active disease from RCTs illustrated several known and some new targets for SLE treatment (POS0351). Markers of pathways

Read Article

Combination vs. Sequential Therapy for the Treatment of Lupus Nephritis

Jun 08, 2021

Combination disease modifying antirheumatic drug (DMARD) therapy may not be only for rheumatoid arthritis; combining disease modifying agents may be the path to better renal response. 

Read Article

Promising options to treat mucocutaneous disease in SLE

Cutaneous lupus erythematosus (CLE) consists of a wide range of dermatologic manifestations seen in people with or without systemic lupus erythematosus (SLE). CLE can be categorised into LE-specific lesions, i.e. acute CLE (ACLE), subacute CLE (SCLE) and chronic CLE (CCLE), and nonspecific LE

Read Article
Current approach to lupus and pregnancy by Dr. Robert Chao ( @doctorRBC) #EULAR2021 https://t.co/eFd6j9YZo5 https://t.co/tW9tJIRpjm
Dr. John Cush @RheumNow( View Tweet )
Jun 08, 2021
#EULAR2021 - Day 3 Report https://t.co/X7zxsKW8eL https://t.co/OKu5Mgodlo
Dr. John Cush @RheumNow( View Tweet )
Jun 08, 2021

EULAR 2021 - Day 3 Report

Jun 07, 2021

Here are a few notable presentations from this past Friday, Day 3 of the EULAR 2021 virtual meeting.

Read Article

Israel provides COVID vaccine answers for rheumatic disease patients

Jun 07, 2021

The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress, data presented from Israel, one of the first countries to vaccinate on a broad scale, has

Read Article
Video: IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus Dr. Yuz Yusof speaks with Dr. Lucy Carter about abstract OP0134, presented at the virtual #EULAR2021 meeting. https://t.co/pqr8uRBiRG https://t.co/lhvuYIfI34
Dr. John Cush @RheumNow( View Tweet )
Jun 07, 2021
Video: Prevalence of Long Term HCQ in Retinal Toxicity: Dr. Kathryn Dao (@KDAO2011 ) Dr. Kathryn Dao reviews abstract OP0133, "The Prevalence and Risk Factors of Retinal Toxicity Associated with Long-Term Hydroxychloroquine Use", presented at #EULAR2021. https://t.co/tZyXQhZgLG https://t.co/x6AfItFWEU
Dr. John Cush @RheumNow( View Tweet )
Jun 07, 2021
Excellent talk on SLE, APS abs pregancy ⭐️pregnancy counseling is important ⭐️aspirin 81mg in all pregnant SLE pts ⭐️do not discontinue HCQ ⭐️stable LN - can switch MMF to AZA Abs#6888 #EULAR2021 @RheumNow

Robert B Chao, MD @doctorRBC( View Tweet )

Jun 06, 2021
Close call between LLDAS and DORIS Remission as a treat-to-target in #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/r3OnSrmQkH

Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )

Jun 06, 2021
Results are out. The majority would use #anifrolumab to treat refractory skin and joints disease #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/wguBCkhZ7B

Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )

Jun 06, 2021
6. Rheum disease activity was stable with COVID vaccination. (RA, PsA, axSpA, SLE - total n = 597) 7/ LB0003 #EULAR2021 @RheumNow https://t.co/xxkrunjPa0
David Liew @drdavidliew( View Tweet )
Jun 06, 2021
×